Reply to: Assessing feasibility and safety of hydroxyethyl starch as priming solution of cardiopulmonary bypass
Perfusion
.
2018 Sep;33(6):498-499.
doi: 10.1177/0267659118768145.
Epub 2018 Apr 23.
Authors
Ø S Svendsen
1
,
M Farstad
1
,
A Mongstad
2
,
R Haaverstad
2
3
,
P Husby
1
4
,
V L Kvalheim
2
3
Affiliations
1
1 Department of Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
2
2 Section for Cardiothoracic Surgery, Department for Heart Disease, Haukeland University Hospital, Bergen, Norway.
3
3 Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
4
4 Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
PMID:
29683376
DOI:
10.1177/0267659118768145
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiopulmonary Bypass*
Hydroxyethyl Starch Derivatives*
Plasma Substitutes
Substances
Hydroxyethyl Starch Derivatives
Plasma Substitutes